Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (463)	4/15/2000 8:44:00 AM
From: Mike K	Respond to of 555

A strategy that I have used quite successfully in the last year to build a biotech portfolio has been to start with small long positions and also use short puts, and short and long calls. Over time, I've lightened or added to the positions to lock in profits, but always maintained a short put position to stay in the stocks I like. With the latest downturn put premiums are looking attractive for some of my favorite stocks. These include; CELG, INCY, GLIA, IMNX, CLTR, IDPH & CORR. Will be looking a the short puts for these stocks next week with interest. CELG should be active as it starts trading post-split on Monday. Don't forget April options expiration is next Thursday with Friday being a holiday. Cheers, Mike